KORU Medical Systems, Inc. (KRMD)

Market Cap	155.96M
Revenue (ttm)	35.08M
Net Income (ttm)	-5.30M
Shares Out	46.14M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	241,267
Open	3.280
Previous Close	3.250
Day's Range	3.200 - 3.450
52-Week Range	1.860 - 5.050
Beta	0.43
Analysts	Strong Buy
Price Target	4.63 (+36.98%)
Earnings Date	Aug 6, 2025

About KRMD

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 80
• Stock Exchange: NASDAQ
• Ticker Symbol: KRMD
• Website: https://www.korumedical.com

Financial Performance

In 2024, KORU Medical Systems's revenue was $33.65 million, an increase of 17.98% compared to the previous year's $28.52 million. Losses were -$6.07 million, -55.85% less than in 2023.

Analyst Forecast

According to 4 analysts, the average rating for KRMD stock is "Strong Buy." The 12-month stock price forecast is $4.63, which is an increase of 36.98% from the latest price.

Price Target

$4.63

(36.98% upside)

Analyst Consensus: Strong Buy